These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 17086470)

  • 1. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial.
    Majumdar SR; Johnson JA; Lier DA; Russell AS; Hanley DA; Blitz S; Steiner IP; Maksymowych WP; Morrish DW; Holroyd BR; Rowe BH
    Osteoporos Int; 2007 Mar; 18(3):261-70. PubMed ID: 17086470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a multifaceted intervention to improve quality of osteoporosis care after wrist fracture.
    Majumdar SR; Lier DA; Rowe BH; Russell AS; McAlister FA; Maksymowych WP; Hanley DA; Morrish DW; Johnson JA
    Osteoporos Int; 2011 Jun; 22(6):1799-808. PubMed ID: 20878389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture.
    Majumdar SR; Rowe BH; Folk D; Johnson JA; Holroyd BH; Morrish DW; Maksymowych WP; Steiner IP; Harley CH; Wirzba BJ; Hanley DA; Blitz S; Russell AS
    Ann Intern Med; 2004 Sep; 141(5):366-73. PubMed ID: 15353428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study.
    Majumdar SR; Johnson JA; Bellerose D; McAlister FA; Russell AS; Hanley DA; Garg S; Lier DA; Maksymowych WP; Morrish DW; Rowe BH
    Osteoporos Int; 2011 Jan; 22(1):223-30. PubMed ID: 20358359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA;
    Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of osteoporosis interventions for 'incidental' vertebral fractures.
    Majumdar SR; Lier DA; McAlister FA; Rowe BH; Siminoski K; Hanley DA; Russell AS; Johnson JA
    Am J Med; 2013 Feb; 126(2):169.e9-17. PubMed ID: 23331449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial.
    Majumdar SR; Johnson JA; McAlister FA; Bellerose D; Russell AS; Hanley DA; Morrish DW; Maksymowych WP; Rowe BH
    CMAJ; 2008 Feb; 178(5):569-75. PubMed ID: 18299546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.
    Yong JH; Masucci L; Hoch JS; Sujic R; Beaton D
    Osteoporos Int; 2016 Jan; 27(1):231-40. PubMed ID: 26275439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.
    Parthan A; Kruse M; Agodoa I; Silverman S; Orwoll E
    Bone; 2014 Feb; 59():105-13. PubMed ID: 24231131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of two inexpensive postfracture osteoporosis interventions: results of a randomized trial.
    Majumdar SR; Lier DA; Leslie WD
    J Clin Endocrinol Metab; 2013 May; 98(5):1991-2000. PubMed ID: 23596140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men.
    Schousboe JT; Taylor BC; Fink HA; Kane RL; Cummings SR; Orwoll ES; Melton LJ; Bauer DC; Ensrud KE
    JAMA; 2007 Aug; 298(6):629-37. PubMed ID: 17684185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial.
    Merle B; Chapurlat R; Vignot E; Thomas T; Haesebaert J; Schott AM
    Osteoporos Int; 2017 May; 28(5):1549-1558. PubMed ID: 28246884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial.
    Majumdar SR; Lier DA; Beaupre LA; Hanley DA; Maksymowych WP; Juby AG; Bell NR; Morrish DW
    Arch Intern Med; 2009 Jan; 169(1):25-31. PubMed ID: 19139320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial.
    Cranney A; Lam M; Ruhland L; Brison R; Godwin M; Harrison MM; Harrison MB; Anastassiades T; Grimshaw JM; Graham ID
    Osteoporos Int; 2008 Dec; 19(12):1733-40. PubMed ID: 18629567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Osteoporosis Interventions to Improve Quality of Care After Upper Extremity Fracture: Results From a Randomized Trial (C-STOP Trial).
    Majumdar SR; Lier DA; McAlister FA; Johnson JA; Rowe BH; Beaupre LA
    J Bone Miner Res; 2019 Jul; 34(7):1220-1228. PubMed ID: 30779861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.
    Moriwaki K; Fukuda H
    Osteoporos Int; 2019 Feb; 30(2):299-310. PubMed ID: 30610244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: a retrospective case-control analysis.
    Cotté FE; Mercier F; De Pouvourville G
    Clin Ther; 2008 Dec; 30(12):2410-22. PubMed ID: 19167600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.
    Ni W; Jiang Y
    Osteoporos Int; 2017 Feb; 28(2):529-538. PubMed ID: 27581955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US.
    Parthan A; Kruse M; Yurgin N; Huang J; Viswanathan HN; Taylor D
    Appl Health Econ Health Policy; 2013 Oct; 11(5):485-97. PubMed ID: 23868102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis.
    Hiligsmann M; Ethgen O; Bruyère O; Richy F; Gathon HJ; Reginster JY
    Value Health; 2009; 12(5):687-96. PubMed ID: 19508659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.